Friday, January 20, 2023 Sunnybrook study measures the impact of expanding critical care capacity beyond the ICU
The study demonstrates the impact humidified oxygen therapy, known as high-flow nasal cannula (HFNC) oxygen therapy, had on patients and hospital resources.
Wednesday, January 18, 2023 INOVAIT invests in the Canadian image-guided therapy sector through its Focus Fund
Fund from Sunnybrook-led network will inject up to $22.7 million into the image-guided therapy sector to ultimately deliver better health care to Canadians
Friday, December 23, 2022 New Platform Director, Biological Sciences
Dr. JoAnne McLaurin is currently a senior scientist in Biological Sciences and the Hurvitz Brain Sciences Research Program at SRI and holds a Tier 1 Canada Research Chair in Alzheimer’s Disease Therapeutics.
Thursday, December 22, 2022 Driving and Dementia Roadmap: A new resource on a World Health Organization Global Dementia Platform
An online Canadian online resource about driving and dementia developed by a team of researchers, including Dr. Mark Rapoport at Sunnybrook, has been recognized as a dementia resource on a World Health Organization platform.
Friday, December 16, 2022 How proper use of a CPAP is linked to improved thinking in people with sleep apnea
A new study by Sunnybrook researchers has found that using continuous positive airway pressure (CPAP) therapy appropriately is linked with improved thinking and memory in patients with obstructive sleep apnea who have cognitive impairment.
